This week's roundup of Houston innovators includes Barbar Burger of Chevron, David Aaronson of REVs, and Andrea Young of DonateStock. Courtesy photos

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from energy to fintech — recently making headlines in Houston innovation.

Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures

The InnovationMap Awards will celebrate Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, as this year's Trailblazer Award honoree. Photo courtesy of CTV

The inaugural Trailblazer Award at the 2021 InnovationMap Awards event was established to honor a Houston innovation leader and advocate who's making a lasting impact on the Houston innovation community. Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, was selected to receive award.

"I am deeply honored to be recognized for my contributions to the Houston Innovation Ecosystem. I moved to Houston in 2013 and in short order was included and saw ways I could contribute. That is a great welcome! While I am proud of my contributions and our progress, we are just getting started," Burger says.

Burger leads Chevron's corporate venture arm, Chevron Technology Ventures, which has invested millions in the future of energy technology. This type of corporate venture activity — especially in a city with so many Fortune 500 companies — plays a key role in an innovation community. Click here to read more.

David Aaronson, founder of REVS

David Aaronson of REVS shares his EV entrepreneurial journey on the Houston Innovators Podcast. Photo courtesy of REVS

It might not be today, and it might not be tomorrow, but electric vehicles are coming into Texas at an increasing rate. EVolve Houston, founded in part by the city, predicts that EV sales locally will make up 30 percent of annual new car sales by 2030. Aaronson says they reported that Houston has around 15,000 EVs on the road today, but by 2030, that's going to be 600,000.

"If it's not 2030 it's going to be 2032, because it's all the manufacturers are making," David Aaronson, founder of REVS, says on this week's episode of the Houston Innovators Podcast. "It's just a matter of time."

Aaronson, a Houston real estate veteran, founded Refuel Electric Vehicle Solutions, or REVS, last year to become the go-between for multifamily property owners and managers and the charging technology providers. Click here to read more and stream the episode.

Andrea Young, co-founder and CEO of DonateStock

DonateStock, a Houston fintech company that simplifies the stock donation process, has officially launched. Image courtesy of DonateStock

A few years back, Andrea Young donated some of her stock, and the process, while having its perks, wasn't worth the trouble.

"I valued the immense benefits stock donations provided me as an investor while simultaneously helping a nonprofit," Young says of her early experience with donating stock. "I enjoyed the significant tax advantages that allowed me to avoid capital gains taxes while deducting the full market value of my gifted stock. However, I found the entire process time consuming and cumbersome, which led to the end of my stock donation journey."

When the pandemic hit and nonprofits were greatly impacted, Young and her co-founder saw an opportunity to found DonateStock to help drive donations and guide nonprofits and donors alike through the process. During its beta testing phase, the company partnered with almost 100 nonprofits. Click here to read more.

DonateStock, a Houston fintech company that simplifies the stock donation process, has officially launched. Image courtesy of DonateStock

Impact-driven Houston fintech startup officially launches after successful beta

it's go time

Keep reading...Show less
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston cleantech, space startups named to World Economic Forum cohort

top honor

Two Houston-based startups have been selected to join the World Economic Forum's Technology Pioneers community.

The two-year program aims to help mission-driven, early-stage start-ups scale their innovations through multi-stakeholder initiatives, co-creating partnerships and other gatherings for community members. One-hundred startups are selected each year from around the globe, this year hailing from 23 countries and working in AI, energy, space, biotech markets and more.

Cleantech startup Vaulted Deep was one of 11 energy and climate companies to be named to the cohort. Julia Reichelstein and Omar Abou-Sayed founded the company in 2023. Its technology injects excess organic waste underground to remove carbon dioxide from the atmosphere.

Last year, Vaulted Deep inked a 12-year deal with Microsoft to remove up to 4.9 million metric tons of carbon dioxide from the environment.

The startup has earned several accolades in recent years, including a No. 3 spot on Fast Company’s list of the World’s Most Innovative Companies of 2026. It was also recently named to market intelligence and advisory firm Cleantech Group's annual Global Cleantech 100 list for a second year in a row.

"Waste management is one of the world's great invisible infrastructure systems ... The need for new infrastructure is growing as disposal challenges become more complex and regulations evolve. Vaulted is building the first new disposal pathway for organic waste in decades by putting it deep underground, permanently," the company shared in a LinkedIn post. "This year, we're joining the World Economic Forum's 2026 Tech Pioneers alongside innovators working on the many interconnected challenges shaping our future."

Houston-based Venus Aerospace was also selected to join the cohort, along with six other spacetech companies. The company was founded in 2020 by Sassie and Andrew Duggleby.

The startup specializes in next-generation rocket engine propulsion as a cleaner alternative to traditional combustion engines. The company's rotating detonation rocket engine (RDRE) burns fuel more efficiently and completed a successful high-thrust test flight last year. Venus says it’s the only company in the world that makes a flight-proven, high-thrust RDRE with a “clear path to scaled production.”

"Frontier technologies matter most when they expand what people, industries, and nations can do," Sassie Duggleby, co-founder and CEO of Venus, said in a news release. "For Venus, RDRE does not just represent a more efficient engine. It is a foundation for faster movement, more capable space systems, and new forms of connectivity across the planet. Being named a Technology Pioneer validates the potential of this technology to help shape a future where distance is less limiting."

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston Methodist receives record $110M gift, names future tower

historic gift

Houston Methodist has received the largest gift in the health system's history to establish new funds for neurological, neuroscience, and women’s health research and treatment.

The $110 million gift comes from Houston-based The Brockman Medical Research Foundation, which supports education and research in the science, medicine and healthcare fields. In response, Houston Methodist announced that it will name its forthcoming 26-story hospital facility the Brockman Centennial Tower.

The tower’s entrance will be named the Anna Margaret Bellows Centennial Hall to honor Anna Margaret Bellows, a young camper who died during the Camp Mystic flooding last summer.

“This extraordinary gift accelerates discovery and transforms how care is delivered,” Dr. Marc Boom, president and CEO of Houston Methodist, said in a news release. “We are grateful to The Brockman Medical Research Foundation for its incredible generosity and vision that will help change the lives of generations of patients. Naming Centennial Tower in recognition of this gift reflects the scale of this commitment and its impact on the future of neuroscience, neurological care and women’s health.”

The gift will be divided into two parts:

  • $100 million will go toward creating an innovation fund within the Houston Methodist Academic Institute and the Houston Methodist Neurological Institute
  • $10 million will be devoted to Houston Methodist's Department of Obstetrics and Gynecology

“This tremendous gift will accelerate translational research that broadens our understanding of neurological and other diseases,” Dr. Jenny Chang, president and CEO of the Houston Methodist Academic Institute, added in the release. “It will allow us to leverage state-of-the-art platforms to detect, diagnose and deliver therapeutics, keeping patient care at the center of our mission.”

The Brockman Centennial Tower is expected to open next year in the Texas Medical Center. Spanning more than 1 million square feet, it will house 400 patient beds, an expanded emergency department, new operating rooms and a rooftop garden. It will be connected to Houston Methodist's flagship Paula and Joseph C. “Rusty” Walter III Tower, which opened in 2018. The Centennial Tower was estimated to cost $1.4 billion when announced in 2022.

In addition to the news of the Brockman gift, Houston Methodist also announced this month that it has launched the Houston Methodist Center for Cell and Gene Therapy and tapped an internationally recognized scientist as its leader.

The new center is focused on discovering and developing innovative and cost-effective therapies for a variety of congenital and acquired diseases, including cancer, HIV and cardiovascular disease.

Dr. Malcolm Brenner has been named as the center's inaugural leader and will assume the role starting in October. He will work alongside scientists and support staff from Baylor College of Medicine and Texas Children's Hospital.

Brenner is a professor of pediatrics, medicine, molecular and human genetics and translational biology at Baylor College of Medicine. He is known for making early advances in using bone marrow transplantation as a form of cell therapy and in engineered immune-cell treatments for cancer and infections, according to a release from Houston Methodist.

“Malcolm Brenner is a pioneer in the field of cell and gene therapy and is uniquely qualified to lead Houston Methodist’s research efforts in this field,” Chang added. “His vision and leadership will play a pivotal role in advancing our work in this space.”